Correctly distinguishing between related neurodegenerative diseases remains challenging for clinicians, because reliable markers do not yet exist for many disorders. In the July 22 Neurology, ...
Visual Abstract. Comparison of FDG PET 3D-SSP z score maps and transaxial slices of the temporal lobe, along with corresponding MRI images, among individuals suspected of having Alzheimer's disease ...
(Barcelona, Spain, Wednesday 8 September 2025) The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research presented today at the 38th Annual ...
Unveiling consistency: A large-scale analysis of conference proceedings and subsequent publications in oncology clinical trials using large language models. This is an ASCO Meeting Abstract from the ...
Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...